- $491.54m
- $391.49m
- $445.25m
- 32
- 57
- 52
- 45
Annual cashflow statement for Sharecare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39.4 | -60.5 | -85.1 | -119 | -130 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.808 | 25.2 | 28.7 | 53.5 | 49.8 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 17.7 | 27 | -28 | -28.7 | 5.2 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.58 | 14.8 | -54.1 | -49.7 | -14 |
| Capital Expenditures | -1.7 | -1.81 | -2.42 | -3.69 | -1.63 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -14.9 | -17.4 | -110 | -40.7 | -27.1 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -16.6 | -19.2 | -112 | -44.4 | -28.8 |
| Financing Cash Flow Items | 0 | -0.072 | 426 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.8 | 3.77 | 415 | 5.51 | -11.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.59 | -1.07 | 249 | -88.6 | -54.3 |